The global mobile cardiac telemetry systems market is estimated to expand at a considerable CAGR during the forecast period, 2021–2028. Mobile cardiac telemetry (MCT) is a ECG monitoring method which utilizes a compact portable device to keep track of the patient’s cardiac activity. It is an effective technique of monitoring cardiac activity throughout day and night. Cardiac monitoring requires constant examination of the heart via electrocardiography and helps spot irregularities in the working of the heart. Cardiac activity monitoring is an indispensable part of health care diagnosis, owing to the rhythm of the heart being linked with several functions of the human body. Remote cardiac telemetry is a new development in the field, which monitors cardiac activity from remote locations. Some MCT systems provide beat-to-beat analysis by measuring each heartbeat over a 24-hour period.
The report on the global mobile cardiac telemetry systems market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes | Details |
Report Title | Mobile Cardiac Telemetry Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Applications (Lead-based and Patch-based), End-uses (Hospitals, Cardiac centers, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered | ACS Diagnostics, BioTelemetry, Inc., iRhythm Technologies, Inc., Medicalgorithmics, S.A., Medicomp Inc, Preventice Solutions, Inc., ScottCare Corporation, Telerhythmics, LLC, and Welch Allyn |
Segment Insights:
Lead-based segment to account for a sizeable market share
On the basis of applications, the market can be segmented into lead-based and patch-based. The lead-based segment accounted for a high revenue share in 2019 and is estimated to grow further during the forecast period, 2021-2028. This can be attributed to the light weight and easy-to-use nature of lead-based MCTs, which are preferred by several patients.
Hospitals segment to grow at a rapid pace
In terms of end-uses, the global mobile cardiac telemetry systems market can be divided into hospitals, cardiac care centers, and others. The hospitals segment is anticipated to dominate the market with a significant revenue share. The growth of the segment can be accredited to the rising number of non-invasive surgeries, the ubiquitous nature of hospitals and easy access to hospitals. Additionally, favorable reimbursement policies are projected to boost the demand during the forecast period, 2021-2028.
North America holds a key share of the global market
Based on regions, the global mobile cardiac telemetry systems market can be classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America segment held a key share in the global market in terms of revenue for mobile cardiac telemetry in 2019 and is expected to grow further during the forecast period, 2021-2028. This growth can be attributed to diverse aspects which includes rising geriatric population and increasing healthcare expenditure. According to the Administration for Community Living, a 33% rise in the geriatric population has been observed in the US in the past decade. The market in the region is occupied by several healthcare service providers, which is anticipated to boost the market growth further during the forecast period.
Some other reports from this category!